Related Experiment Video
Updated: Jun 25, 2026
12:27
A Pipeline to Investigate the Structures and Signaling Pathways of Sphingosine 1-Phosphate Receptors
Published on: June 8, 2022
Sphingosine 1-phosphate receptor signaling.
Hugh Rosen1, Pedro J Gonzalez-Cabrera, M Germana Sanna
1Departments of Chemical Physiology and Immunology and The Scripps Research Institute Molecular Screening Center, The Scripps Research Institute, La Jolla, CA 92037, USA. hrosen@scripps.edu
Annual Review of Biochemistry
|February 24, 2009
Summary
The sphingosine 1-phosphate (S1P) system regulates vascular integrity and homeostasis. Modulating S1P receptor signaling offers potential therapies for diseases like multiple sclerosis.
Area of Science:
- Biochemistry and Molecular Pharmacology
- Physiology
Background:
- The sphingosine 1-phosphate (S1P) receptor signaling system involves a hydrophobic lysophospholipid ligand interacting with five G protein-coupled receptors.
- This system critically modulates homeostasis and pathology, with essential roles in vascular development and endothelial integrity.
Purpose of the Study:
- To explore the integrated biochemical system of S1P receptor signaling.
- To highlight the importance of developing specific chemical tools for real-time signal modulation.
- To underscore the therapeutic potential of targeting the S1P system.
Main Methods:
- Investigated the complex interactions within the S1P receptor signaling pathway.
- Utilized chemical and genetic approaches to understand signal modulation.
- Focused on receptor subtype-selectivity and signal attenuation strategies.
Main Results:
- Demonstrated the dual role of S1P in vascular development and potential cardiac toxicity.
- Showcased how specific chemical tools complement genetic insights.
- Identified the system's delicate balance, essential for its function.
Conclusions:
- The S1P receptor system, despite its complexity and narrow therapeutic window, is a promising target for treating diseases.
- Targeting S1P receptor signaling, particularly through subtype-selective modulation, is nearing clinical application for multiple sclerosis.
- Understanding the interplay of chemistry and genetics is crucial for advancing S1P-based therapeutics.
More Related Videos
Related Concept Videos
01:11IP3/DAG Signaling Pathway
Membrane lipids such as phosphatidylinositol (PI) are precursors for several membrane-bound and soluble second messengers. Specific kinases phosphorylate PI and produce phosphorylated inositol phospholipids. One such inositol phospholipids are the phosphatidylinositol-4,5 bisphosphate [PI(4,5)P2], present in the inner half of the lipid bilayer. Upon ligand binding, GPCR stimulates Gq proteins to turn on phospholipase Cꞵ. Activated phospholipase Cꞵ cleaves PI(4,5)P2 and produces two-second...
01:22Amplifying Signals via Enzymatic Cascade
When a ligand binds to a cell-surface receptor, the receptor's intracellular domain changes shape, which may either activate its enzyme function or allow its binding to other molecules. The initial signal is amplified by most signal transduction pathways. This means that a single ligand molecule can activate multiple molecules of a downstream target. Proteins that relay a signal are most commonly phosphorylated at one or more sites, activating or inactivating the protein. Kinases catalyze the...
01:15Amplifying Signals via Second Messengers
Many receptor binding ligands are hydrophilic; they do not cross the cell membrane but bind to cell-surface receptors. Thus, their message must be relayed by second messengers present in the cell cytoplasm. There are several second messenger pathways, each with its own way of relaying information. For example, the G protein-coupled receptors can activate both phosphoinositol and cyclic AMP (cAMP) second messenger pathways. The phosphoinositol pathway is active when the receptor induces...
01:21Cell-surface Signaling
Hormones—or any molecule that binds to a receptor, known as a ligand—that are lipid-insoluble (water-soluble) are not able to diffuse across the cell membrane. In order to be able to affect a cell without entering it, these hormones bind to receptors on the cell membrane. When a first messenger, a hormone, binds to a receptor, a signal cascade is set off, causing second messengers, proteins inside the cell, to become activated, resulting in downstream effects.
01:12What are Second Messengers?
Because many receptor binding ligands are hydrophilic, they do not cross the cell membrane and thus their message must be relayed to a second messenger on the inside. There are several second messenger pathways, each with their own way of relaying information. G-protein coupled receptors can activate both phosphoinositol and cyclic AMP (cAMP) second messenger pathways. The phosphoinositol path is active when the receptor induces phospholipase C to hydrolyze the phospholipid,...
01:30Assembly of Signaling Complexes
Multiprotein signaling complexes are formed in a dynamic process involving protein-protein interactions at the cytoplasmic domain of transmembrane receptors or enzymatic and non-enzymatic proteins associated with the receptor. These complexes ensure the activation and propagation of intracellular signals that regulate cell functions.
Interaction domains in cell signaling
Interaction domains recognize exposed features of their binding partners containing post-translationally modified sequences,...
Interaction domains in cell signaling
Interaction domains recognize exposed features of their binding partners containing post-translationally modified sequences,...